Research Topics
Genomes and GenesSpecies | Henry MankinSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Diagnosis, classification, and management of soft tissue sarcomasHenry J Mankin
Massachusetts General Hospital, Boston, MA 02114, USA
Cancer Control 12:5-21. 2005..Advances in imaging, as well as improvements in surgical techniques and adjunctive treatment methods, have improved care for patients with these unusual disorders...
Total femur replacement procedures in tumor treatmentHenry J Mankin
Orthopaedic Oncology Service, Massachusetts General Hospital and the Harvard Medical School, Boston, MA 02114, USA
Clin Orthop Relat Res 438:60-4. 2005..LEVEL OF EVIDENCE: Therapeutic study, Level IV-1 (case series). See the Guidelines for Authors for a complete description of levels of evidence...
Treatment of proximal humeral chondrosarcoma with resection and allograftAnastasios Mourikis
Orthopaedic Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston, Mass 02114, USA
J Shoulder Elbow Surg 16:519-24. 2007....
Pleomorphic spindle cell sarcoma (PSCS) formerly known as malignant fibrous histiocytoma (MFH): a complex malignant soft-tissue tumorH J Mankin
Department of Orthopaedic Oncology, Massachusetts General Hospital, Boston, MA, USA
Musculoskelet Surg 96:171-7. 2012....
Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathwayKeinosuke Ryu
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA 02114, USA
BMC Cancer 10:187. 2010....
A questionnaire study for 128 patients with Gaucher diseaseH J Mankin
The Massachusetts General Hospital, Boston, MA 02114, USA
Clin Genet 69:209-17. 2006..The results show that many of the patients still have fairly extensive problems, which could possibly be helped by some alterations in treatment protocols...
Internal hemipelvectomy for the management of pelvic sarcomasHenry J Mankin
Orthopaedic Oncology Service, Massachusetts General Hospital, Harvard Medical School, Gray 6 Orthopaedics, Boston, 02114, USA
Surg Oncol Clin N Am 14:381-96. 2005
Paget's sarcoma: a historical and outcome reviewHenry J Mankin
Orthopaedic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Clin Orthop Relat Res 438:97-102. 2005..LEVEL OF EVIDENCE: Prognostic study, Level IV (case series). See the Guidelines for Authors for a complete description of levels of evidence...
Pigmented villonodular synovitis of jointsHenry Mankin
Department of Orthopaedics, Massachusetts General Hospital, Boston, Massachusetts, USA
J Surg Oncol 103:386-9. 2011..The 215 cases from our hospital are current (1972-2009) and those 62 from the Jaffe collection from 1920 to 1968...
Aneurysmal bone cyst: a review of 150 patientsHenry J Mankin
Orthopedic Oncology Service, Orthopedic Surgery, Massachusetts General Hospital, Boston, MA 02114, USA
J Clin Oncol 23:6756-62. 2005..We have reviewed a series of 150 aneurysmal bone cysts treated over the last 20 years...
Erlenmeyer flasking of a child's bones: a diagnostic puzzleHenry J Mankin
Orthopaedic Oncology Service and Developmental Neurogenetics Clinic, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
Am J Orthop 34:393-5. 2005
Treatment of giant cell tumors with allograft transplants: a 30-year studyHenry J Mankin
Orthopaedic Oncology Service, Massachusetts General Hospital, Boston, MA 02114, USA
Clin Orthop Relat Res 439:144-50. 2005....
A happy outcome to a bad problemHenry J Mankin
Orthopaedic Oncology and Reproductive Endocrinology Services, Massachusetts General Hospital, Boston, MA 02114, USA
J Bone Joint Surg Am 84:1251-3. 2002
Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: a biologic and clinical reviewHenry J Mankin
Orthopaedic Research Laboratories, Massachusetts General Hospital, Boston, MA 02114, USA
Chir Organi Mov 93:1-7. 2009..In addition, these patients have some systemic and dermal findings resembling those seen in patients with Type 1 neurofibromatosis...
Characterization and analysis of human chordoma cell linesCao Yang
Department of Orthopaedic Surgery, Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Spine (Phila Pa 1976) 35:1257-64. 2010..An experimental study to investigate the characterization of 3 chordoma cell lines...
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcomaMichiro Susa
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
PLoS ONE 5:e10764. 2010..However, for patients who progress after chemotherapy, its effectiveness diminishes due to the emergence of multi-drug resistance (MDR) after prolonged therapy...
RAIDD expression is impaired in multidrug resistant osteosarcoma cell linesCao Yang
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA 02114, USA
Cancer Chemother Pharmacol 64:607-14. 2009..To identify the apoptosis genes involved in the multidrug resistant phenotype of osteosarcoma...
The kinase Mirk is a potential therapeutic target in osteosarcomaCao Yang
Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Carcinogenesis 31:552-8. 2010..This highlights Mirk's potential to serve as a promising target for molecular therapy in the treatment of osteosarcoma...
Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cellsCao Yang
Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Cancer Chemother Pharmacol 67:439-46. 2011..To better understand the mechanisms of cytotoxicity and cell death induced by HDACI PCI-24781 in bone sarcoma cells...
Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivoXianzhe Liu
Department of Orthopaedic Surgery, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Anticancer Drugs 22:444-53. 2011..Finally, in mouse osteosarcoma xenografts, BI 2536-treated mice had significantly smaller tumors compared with the control mice. These findings offer evidence of the potential role for targeting PLK1 in osteosarcoma therapy...
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcomaZhenfeng Duan
Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
Cancer Lett 293:220-9. 2010..The development of more potent inhibitors that target PLK1 may open doors to a new range of anti-cancer strategies in osteosarcoma...
Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expressionCao Yang
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA 02114, USA
Apoptosis 14:124-33. 2009..These results suggest that GADD45alpha may play a role in drug-induced apoptosis, as well as multidrug resistance in osteosarcoma cells...
ROCK1 as a potential therapeutic target in osteosarcomaXianzhe Liu
Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
J Orthop Res 29:1259-66. 2011..These findings suggest that knockdown of ROCK1 inhibits proliferation and induces apoptosis in osteosarcoma cell lines. ROCK1 may be a promising therapeutic target for the treatment of osteosarcoma patients...
MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migrationZhenfeng Duan
Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
Mol Cancer Ther 10:1337-45. 2011..Restoring miR-199a-3p's function may provide therapeutic benefits in osteosarcoma...
Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor traffickingMichiro Susa
Department of Orthopaedic Surgery, and SarcomaBiology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
Mol Cancer Ther 9:3342-50. 2010..In conclusion, our results suggest that osteosarcoma cell proliferation and survival are dependent on GAK. These findings may lead to the development of new therapeutic options for osteosarcoma...
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expressionZhenfeng Duan
Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Orthop Res 28:746-52. 2010..Our results demonstrate that some miRNAs are differentially expressed in chordoma and, in particular, miRNA-1 may have a functional effect on chordoma tumor pathogenesis...
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcomaMichiro Susa
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA 02114, USA
BMC Cancer 9:399. 2009....
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell linesZhenfeng Duan
Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Jackson Building, Boston, Massachusetts 02114, USA
Mol Cancer Ther 8:2122-30. 2009..Our data suggest that inhibition of IGF-IR with PPP offers a novel and selective therapeutic strategy for ostosarcoma, and at the same time, PPP is effective at reversing the drug-resistant phenotype in osteosarcoma cell lines...
Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosisKeinosuke Ryu
Department of Orthopedic Surgery, Massachusetts General Hospital, Center for Sarcoma and Connective Tissue Oncology, 55 Fruit St Jackson 1115, Boston, Massachusetts 02114, USA
J Orthop Res 28:971-8. 2010..Our results suggest that Stat3 may be a prognostic indicator and potential therapeutic target for osteosarcoma. Blocking the pathway of Stat3 may lead to develop new therapeutic strategies against osteosarcoma...
Targeting hedgehog-GLI-2 pathway in osteosarcomaWen Yang
Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
J Orthop Res 31:502-9. 2013..These findings suggest GLI-2 is required for osteosarcoma cell proliferation and survival. GLI-2 may be exploited as a therapeutic target for the treatment of osteosarcoma patients...
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cellsZhenfeng Duan
Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
Cancer Chemother Pharmacol 63:681-9. 2009..Inhibition is likely achieved through multiple points within these pathways. In a model system of established acquired drug resistance, CCDO-Me is effective at partially reversing the drug-resistance phenotype...
A novel target for treatment of chordoma: signal transducers and activators of transcription 3Cao Yang
Department of Orthopaedic Surgery, Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Mol Cancer Ther 8:2597-605. 2009..In conclusion, the Stat3 pathway is constitutively activated in chordomas and the level of expression may serve as a predictor for prognosis. Blockade of the Stat3 pathway represents a potential strategy for future treatment...
Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assayMichiro Susa
Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Biomol Screen 15:287-96. 2010..The use of NSC77037 to restore sensitivity to chemotherapy or to prevent resistance could be a potential treatment strategy for cancer patients...
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferationZhenfeng Duan
Center for Sarcoma and Connective Tissue Oncology and Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA
Clin Cancer Res 18:4580-8. 2012..Identification of new targeted therapies is critical to improving the survival rate of patients with osteosarcoma. The goal of this study is to identify kinase based potential therapeutic target in osteosarcomas...
Synthesis and evaluation of (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancerZhenfeng Duan
Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Med Chem 55:3113-21. 2012..In conclusion, 11 and derivatives of this compound may hold therapeutic value in the treatment of MDR-dependent cancers...
Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancerYuqi Guo
Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
Clin Cancer Res 16:5759-69. 2010..We then looked for enhancing paclitaxel sensitivity in multidrug-resistant ovarian cancer cell lines...
Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordomaCao Yang
Department of Orthopaedic Surgery, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Spine (Phila Pa 1976) 35:1668-75. 2010..An experimental study to investigate the activation of Src/Stat3 pathways in chordomas and blockage of this pathway as a potential strategy for chordoma treatment...
Alveolar soft part sarcoma: a rare and enigmatic entityMegan E Anderson
Harvard Combined Orthopaedic Oncology Program, Boston, MA 02215, USA
Clin Orthop Relat Res 438:144-8. 2005..LEVEL OF EVIDENCE: Therapeutic study, Level IV-1 (case series). See the Guidelines for Authors for a complete description of levels of evidence...
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordomaJoseph Schwab
Department of Orthopedic Surgery, Section of Orthopedic Oncology, Sarcoma Research Laboratory, Massachusetts General Hospital, Boston, MA 02114, U S A
Anticancer Res 29:1867-71. 2009..PI-103 is a inhibitor of PI3K/AKT and mTOR activation. This study aims to determine whether the PI3K/mTOR pathway was active in chordomas and whether their inhibition could lead to decreased proliferation and increased apoptosis...
Chondromyxoid fibroma: a rarely encountered and puzzling tumorAna Lersundi
Orthopaedic Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Clin Orthop Relat Res 439:171-5. 2005..Tumors treated by excision did not recur. The most difficult problem with chondromyxoid fibroma is pathologic identity because it often is confused with more aggressive tumors that may metastasize...
Distal lower extremity sarcomas: frequency of occurrence and patient survival rateTrisha Zeytoonjian
Orthopaedic Oncology Service, Massachusetts General Hospital, Boston 02114, USA
Foot Ankle Int 25:325-30. 2004..Of perhaps greater interest is the fact that the rate of metastasis and death is markedly reduced for this site as compared with others. The authors speculate on the causes of this remarkable alteration in numbers and outcome...
Imaging of pseudoneoplastic masses associated with allograftsTaj M Kattapuram
Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Yawkey 6036, 55 Fruit Street, Boston, MA 02114, USA
Skeletal Radiol 36:747-53. 2007..The objective of this study is to describe the imaging features of non-neoplastic masses suspected of being tumor recurrences adjacent to allografts. The allografts were utilized for the treatment of various musculoskeletal tumors...
Treatment and outcome of 82 patients with angiosarcomaJohn A Abraham
Orthopedic Oncology, Department of Orthopedics, Massachusetts General Hospital, Yawkey 7B 7926, 55 Fruit Street, Boston, Massachusetts 02114, USA
Ann Surg Oncol 14:1953-67. 2007..Angiosarcomas are an uncommon type of malignancy that are generally thought to behave usually in a locally aggressive fashion; they often metastasize to distant sites...
Osteoblastoma: a 30-year study of 99 casesMicah Berry
Harvard Medical School, Boston, Massachusetts, USA
J Surg Oncol 98:179-83. 2008..In the current study we characterize osteoblastoma by its demographic and anatomic prevalence. We looked at rates of recurrence as related to treatment...
Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumorLily Park
Department of Radiation, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Int J Radiat Oncol Biol Phys 65:1514-21. 2006..To assess the efficacy of definitive treatment of sacral chordoma by high-dose proton/photon-beam radiation therapy alone or combined with surgery...
ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell linesZhenfeng Duan
Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America
PLoS ONE 4:e6967. 2009..ET-743 and PM00104 exposure over sustained periods of treatment will result in the development of drug resistance, but the mechanisms which lead to resistance are not yet understood...
Locking versus standard plates for allograft fixation after tumor resection in children and adolescentsPeter J Buecker
Massachusetts General Hospital, Boston, MA 02114, USA
J Pediatr Orthop 26:680-5. 2006..This investigation was undertaken to assess the performance of locking plates in comparison to standard compression plates for allograft fixation after resection of malignant primary skeletal tumors...
Advantage of limb salvage over amputation for proximal lower extremity tumorsPoonam K Pardasaney
MGH Institute of Health Professions, Boston, Massachusetts 02129, USA
Clin Orthop Relat Res 444:201-8. 2006..Limb salvage offers a functional advantage at proximal tumor locations. Level of Evidence: Therapeutic study, Level III (retrospective, comparative study). See the Guidelines for Authors for a complete description of levels of evidence...
Clear cell sarcoma of soft tissuesSara Sofia Malchau
Orthopaedic Oncology Service, Massachusetts General Hospital, Boston, Massachusetts, USA
J Surg Oncol 95:519-22. 2007..The purpose of this article is to warn the readers of the dangers related to treating this seemingly benign lesion and urge them to perform wide surgery and utilize adjuvant therapy...
Radiation therapy for control of soft-tissue sarcomas resected with positive marginsThomas F DeLaney
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
Int J Radiat Oncol Biol Phys 67:1460-9. 2007..Positive margins (PM) remain after surgery in some soft-tissue sarcoma (STS) patients. We investigated the efficacy of radiation therapy (RT) in STS patients with PM...
Multiple myeloma with a pathologic fracture during pregnancy. A case reportChristopher L Forthman
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Bone Joint Surg Am 86:1284-8. 2004
Malignant transformation of synovial chondromatosis of the shoulder to chondrosarcoma. A case reportAlexander P Sah
Department of Orthopaedic Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
J Bone Joint Surg Am 89:1321-8. 2007
Osteoid osteoma: percutaneous treatment with radiofrequency energyDaniel I Rosenthal
Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 199 Cambridge Street, Boston, MA 02114, USA
Radiology 229:171-5. 2003..To report our experience with technical success, complications, and long-term clinical success of radiofrequency (RF) ablation of osteoid osteoma...
Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomasThomas F DeLaney
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
Int J Radiat Oncol Biol Phys 56:1117-27. 2003..We report the mature outcome data on 48 treated patients and compare them with the data of an historical matched control patient population...
Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesionsAnwar Hau
Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
Skeletal Radiol 31:349-53. 2002..The lowest success rates occurred in 26 patients with infectious diseases (50%). We conclude that these procedures remain the logical and safe choice for diagnostic studies of patients with lesions of the musculoskeletal system...
Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell linesZhenfeng Duan
Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, 100 Blossom St Jackson 1106, Boston, MA 02114, USA
Cancer Chemother Pharmacol 63:1121-9. 2009..The present study was performed to elucidate the relationship between the expression of ABCB1/MDR1 and ABCC1/MRP1 with resistance to either ET-743 or PM00104...
The changes in major limb reconstruction as a result of the development of allograftsHenry J Mankin
Ortopaedic Sevice, Massachussetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Chir Organi Mov 88:101-13. 2003..Secondary infection following operative procedures to repair fracture or graft non-union occurred in 53 cases and reduced the success rate to less then 30%. No patients died of infection...
Adamantinoma: an unusual bone tumourPedro Roque
Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Chir Organi Mov 92:149-54. 2008..Only three of the patients died of disease with the time until death ranging from 10 to 17 years. Recurrence occurred in only three patients and the allograft success rate in terms of function was 71% at a mean time of 10 years...
Langerhans cell histiocytosisKevin Bradford Hoover
Musculoskeletal Radiology, Massachusetts General Hospital, Yawkey 6E 55 Fruit Street, Boston, MA 02114, USA
Skeletal Radiol 36:95-104. 2007..It focuses on the radiographic findings and imaging modalities that are the most useful in disease diagnosis and management...
Giant-cell tumor of the distal forearmNeil G Harness
Orthopaedic Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
J Hand Surg [Am] 29:188-93. 2004....
Jaffe-Campanacci syndrome. A case report and review of the literatureMohammad Anwar Hau
Orthopaedic Oncology Service and Department of Pathology, Maassachusetts General Hospital, Boston 02114, USA
J Bone Joint Surg Am 84:634-8. 2002
Improved survival for sarcomas of the wrist and handPeter J Buecker
Orthopaedic Oncology Service, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Hand Surg Am 31:452-5. 2006..To evaluate survival characteristics of malignant hand tumors compared with those occurring in other musculoskeletal locations over a 30-year period...
Extra-abdominal desmoid tumors: a report of 234 casesHenry J Mankin
Orthopaedic Oncology Service, Massachusetts General Hospital, Boston, Massachusetts 02114, USA hmankin partners org
J Surg Oncol 102:380-4. 2010..To report on the clinical presentation and outcome for 234 patients with extra-abdominal desmoids tumors...
Soft tissue sarcoma resection volume associated with wound-healing complicationsDavid S Geller
Orthopaedic Oncology Service, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA
Clin Orthop Relat Res 459:182-5. 2007..Mean volume of resected tissue in the group of patients treated with primary flap coverage was 1908 cm3, over twice as large as the mean volume of resected tissue in the group of patients treated with primary closure...
Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancerZhenfeng Duan
Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, 100 Blossom Street, Boston, MA 02114, USA
Mol Cancer Ther 7:2377-85. 2008..Finally, overexpression of PRP-4 in drug-sensitive cells could induce a modest level of drug resistance to paclitaxel, doxorubicin, and vincristine...
Lower-extremity lymphangiomatosis. A case report with a seventeen-year follow-upKarl Schultz
Department of Orthopaedic Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
J Bone Joint Surg Am 87:162-7. 2005
Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts General HospitalAndrew J Schoenfeld
Department of Orthopaedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA
Spine J 10:708-14. 2010..Because of the low incidence, treatment recommendations for spinal osteosarcoma are guided by the results of small series and case reports. Many include patients who presented for treatment over the course of three to four decades...
Cyclooxygenase-2 expression in chondrosarcomaKaren M Sutton
Orthopedic Biological Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Oncology 66:275-80. 2004..CONCLUSION: It is evident that COX-2 may play some role in chondrosarcoma but not in the benign enchondroma and that further studies with COX-2 inhibitors are warranted...
Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlationLaurence de Leval
Department of Pathology, Massachusetts General Hospital, Boston, 02114, USA
Am J Surg Pathol 27:1269-77. 2003..0046). In conclusion, a GC-like immunophenotype characterizes roughly half of large B-cell lymphomas of bone and is associated with an improved survival...
Metabolic bone disease: an updateHenry J Mankin
Harvard Medical School, Orthopaedic Oncology Service, Massachusetts General Hospital, Boston, Massachusetts, USA
Instr Course Lect 52:769-84. 2003..Finally, the transfer of calcium across lumens such as the gut, kidney, or bone requires a system, which consists of parathyroid hormone and 1,25-dihydroxyvitamin D and a low phosphate level...
Metabolic bone disease: a review and updateHenry J Mankin
Treadwell Library and Smith Peterson Library, Massachusetts General Hospital, Boston, Massachusetts, USA
Instr Course Lect 57:575-93. 2008..It is essential that orthopaedists recognize these conditions, provide a correct diagnosis, and use appropriate preventive and therapeutic treatments...
Clinical outcome in chordoma: utility of flow cytometry in DNA determinationSigurd Berven
Department of Orthopaedic Surgery, Mount Sinai Medical Center, San Francisco, USA
Spine (Phila Pa 1976) 27:374-9. 2002..A retrospective review of 100 patients with chordoma of the lumbar spine and sacrum. Twenty-three patients had flow cytometry data available and a minimum follow-up period of 5 years...
Osteoarticular and total elbow allograft reconstruction with severe bone lossF Daniel Kharrazi
Kerlan Jobe Orthopaedic Clinic, 6801 Park Terrace Dr, Los Angeles, CA 90045, USA
Clin Orthop Relat Res 466:205-9. 2008..Hemiarticular elbow allograft reconstruction is useful for limb salvage with massive bone loss. Total elbow allograft reconstructions have a high failure rate in the mid-term. LEVEL OF EVIDENCE: Level IV, therapeutic study...
THE CLASSIC: The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. The Journal of Bone and Joint Surgery, 1982;64:1121-1127Henry J Mankin
Clin Orthop Relat Res 450:4-10. 2006
Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. 1986Michael A Simon
J Bone Joint Surg Am 87:2822. 2005
Knee mass from severe metallosis after failure of a metal-backed patellar component total knee arthroplastyF Daniel Kharrazi
Kerlan-Jobe Orthopaedic Clinic, Los Angeles, California 90045, USA
Am J Orthop 37:E38-41. 2008
Guidance on the use of miglustat for treating patients with type 1 Gaucher diseaseNeal J Weinreb
University Research Foundation for Lysosomal Storage Diseases and Northwest Oncology Hematology Associates PA, Coral Springs, Florida
Am J Hematol 80:223-9. 2005....
Research Grants
- METABOLISM IN NORMAL AND OSTEOARTHRITIC CARTILAGEHenry Mankin; Fiscal Year: 1991..The receptors for this cytokine on normal and OA chondrocytes will be quantitated. Further definition of these cartilage metabolic pathways are of primary importance in our understanding of osteoarthritis...
- METABOLISM IN NORMAL AND OSTEOARTHRITIC CARTILAGEHenry Mankin; Fiscal Year: 2001..It is further speculated that the study of serine proteinases produced by OA cartilage may have strong implications for the management of this debilitating disease. ..
